These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 7021295)
1. [Therapy of uremic osteodystrophy]. Fletti C; Docci D; Coli' L; Di Felice A G Clin Med; 1981 Apr; 62(4):270-9. PubMed ID: 7021295 [No Abstract] [Full Text] [Related]
2. [Opinionnaire survey on the treatment of renal osteodystrophy in Japan]. Morii H Nihon Jinzo Gakkai Shi; 1983 Apr; 25(4):439-47. PubMed ID: 6620696 [No Abstract] [Full Text] [Related]
3. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy]. Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442 [TBL] [Abstract][Full Text] [Related]
4. [Renal osteodystrophy during chronic dialysis and transplantation]. Fournier A; Bordier P; Weil B; Safar M; Idatte JM Presse Med (1893); 1971 Oct; 79(45):2007-8. PubMed ID: 4940843 [No Abstract] [Full Text] [Related]
5. Can renal bone disease be prevented? Shaldon S Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119 [No Abstract] [Full Text] [Related]
6. Vitamin D therapy in uremic osteodystrophy: theoretical and practical considerations. Popovtzer MM Int J Artif Organs; 1980 Jan; 3(1):1-4. PubMed ID: 7353907 [No Abstract] [Full Text] [Related]
7. [Therapy of uremic osteopathy]. Schaefer K Dtsch Med Wochenschr; 1980 Nov; 105(48):1670-1. PubMed ID: 7439052 [No Abstract] [Full Text] [Related]
8. [Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis]. Palmieri P; Albertazzi A; Cappelli P; Di Paolo B G Clin Med; 1981 Jul; 62(7):443-60. PubMed ID: 7308629 [No Abstract] [Full Text] [Related]
9. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis]. Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690 [No Abstract] [Full Text] [Related]
10. Renal osteodystrophy in children: progress in its management. Chan JC Clin Pediatr (Phila); 1976 Nov; 15(11):996-1002. PubMed ID: 975714 [No Abstract] [Full Text] [Related]
11. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency]. von Herrath D; Kraft D; Grigoleit HG; Schaefer K Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778 [No Abstract] [Full Text] [Related]
12. Uremic bone disease: current knowledge, controversial issues, and new horizons. Malluche HH; Monier-Faugere MC Miner Electrolyte Metab; 1991; 17(4):281-96. PubMed ID: 1813791 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of renal osteodystrophy: physiopathology and secondary effects]. Haldimann B; Flury W Schweiz Med Wochenschr; 1977 Aug; 107(32):1113-8. PubMed ID: 333572 [TBL] [Abstract][Full Text] [Related]
14. [Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure]. Ishida M; Yamada M Nihon Rinsho; 1991 Dec; 49 Suppl():725-31. PubMed ID: 1808343 [No Abstract] [Full Text] [Related]
15. [Pathophysiology and treatment of renal osteodystrophy]. Ionova D Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143 [No Abstract] [Full Text] [Related]